Fujian Cosunter Pharmaceutical (300436.SZ): Net loss of 36.0378 million yuan in the first half of the year, a decrease in loss compared to the same period last year.

Gelonghui Finance · Aug 27 10:11

Fujian Cosunter Pharmaceutical (300436.SZ) announced its semi-annual report for 2024, with a total operating income of 0.218 billion yuan, a year-on-year increase of 22.93%; net income attributable to shareholders of the listed company -36.0378 million yuan, a year-on-year decrease in loss; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses -48.2001 million yuan, a year-on-year decrease in loss; basic earnings per share -0.2263 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

广生堂(300436.SZ)：上半年净亏损3603.78万元，同比减亏

Fujian Cosunter Pharmaceutical (300436.SZ): Net loss of 36.0378 million yuan in the first half of the year, a decrease in loss compared to the same period last year.

Risk Disclaimer

Statement